“At the moment, we have already met the conditions for a number of positions, in particular for Favipiravir ... and, accordingly, he received a permanent registration certificate,” TASS quotes him.
Earlier, FAS agreed on the maximum price for the drug Favipiravir.
On October 14, the head of the Ministry of Industry and Trade Denis Manturov said that prices for drugs based on favipiravir for the treatment of patients with coronavirus had already more than halved in the country.